82_FR_22765 82 FR 22671 - National Cancer Institute; Notice of Closed Meetings

82 FR 22671 - National Cancer Institute; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 82, Issue 94 (May 17, 2017)

Page Range22671-22671
FR Document2017-09912

Federal Register, Volume 82 Issue 94 (Wednesday, May 17, 2017) 
[Federal Register Volume 82, Number 94 (Wednesday, May 17, 2017)]
[Notices]
[Page 22671]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-09912]



[[Page 22671]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
Board of Scientific Counselors for Clinical Sciences and Epidemiology, 
National Cancer Institute.
    The meeting will be closed to the public as indicated below in 
accordance with the provisions set forth in section 552b(c)(6), Title 5 
U.S.C., as amended for the review, discussion, and evaluation of 
individual intramural programs and projects conducted by the National 
Cancer Institute, including consideration of personnel qualifications 
and performance, and the competence of individual investigators, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.

    Name of Committee: Board of Scientific Counselors for Clinical 
Sciences and Epidemiology, National Cancer Institute.
    Date: July 11, 2017.
    Time: 9:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate personal qualifications and 
performance, and competence of individual investigators.
    Place: National Institutes of Health, 31 Center Drive, Building 
31, C-Wing, 6th Floor, Conference Room 6, Bethesda, MD 20892.
    Contact Person: Brian E. Wojcik, Ph.D., Senior Review 
Administrator, Institute Review Office, Office of the Director, 
National Cancer Institute, National Institutes of Health, 9609 
Medical Center Drive, Room 3W414, Bethesda, MD 20892, 240-276-5664, 
wojcikb@mail.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: May 11, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-09912 Filed 5-16-17; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 82, No. 94 / Wednesday, May 17, 2017 / Notices 22671 DEPARTMENT OF HEALTH AND DEPARTMENT OF HEALTH AND The meetings will be closed to the HUMAN SERVICES HUMAN SERVICES public in accordance with the provisions set forth in sections National Institutes of Health National Institutes of Health 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and National Cancer Institute; Notice of National Center for Advancing the discussions could disclose Closed Meetings Translational Sciences; Notice of confidential trade secrets or commercial Closed Meeting property such as patentable material, Pursuant to section 10(d) of the and personal information concerning Pursuant to section 10(d) of the Federal Advisory Committee Act, as individuals associated with the grant Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is amended (5 U.S.C. App.), notice is applications, the disclosure of which hereby given of a meeting of the Board hereby given of the following meeting. would constitute a clearly unwarranted of Scientific Counselors for Clinical The meeting will be closed to the invasion of personal privacy. Sciences and Epidemiology, National public in accordance with the Name of Committee: National Cancer Cancer Institute. provisions set forth in sections Institute Special Emphasis Panel; Research The meeting will be closed to the 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Centers for Cancer Systems Biology Consortium (CSBC Research Centers). public as indicated below in accordance as amended. The contract proposals and Date: June 22–23, 2017. with the provisions set forth in section the discussions could disclose Time: 8:00 p.m. to 4:00 p.m. 552b(c)(6), Title 5 U.S.C., as amended confidential trade secrets or commercial Agenda: To review and evaluate grant for the review, discussion, and property such as patentable material, applications. evaluation of individual intramural and personal information concerning Place: Gaithersburg Marriott individuals associated with the contract Washingtonian Center, 9751 Washingtonian programs and projects conducted by the Boulevard, Gaithersburg, MD 20878. National Cancer Institute, including proposals, the disclosure of which Contact Person: Delia Tang, MD, Scientific consideration of personnel would constitute a clearly unwarranted Review Officer, Resources and Training qualifications and performance, and the invasion of personal privacy. Review Branch, Division of Extramural competence of individual investigators, Name of Committee: National Center for Activities, National Cancer Institute, NIH, the disclosure of which would Advancing Translational Sciences Special 9609 Medical Center Drive, Room 7W602, Emphasis; Panel Contract Review. Bethesda, MD 20892–9750, 240–276–6456, constitute a clearly unwarranted tangd@mail.nih.gov. Date: June 15, 2017. invasion of personal privacy. Time: 2:30 p.m. to 5:00 p.m. Name of Committee: National Cancer Name of Committee: Board of Scientific Agenda: To review and evaluate contract Institute Special Emphasis Panel; Research Counselors for Clinical Sciences and proposals. Centers for Cancer Systems Biology Epidemiology, National Cancer Institute. Place: National Institutes of Health, Room Consortium (CSBC Research Centers). Date: July 11, 2017. 1073, 6701 Rockledge Drive, Bethesda, MD Date: June 22–23, 2017. 20892 (Telephone Conference Call). Time: 8:00 a.m. to 5:00 p.m. Time: 9:00 a.m. to 4:00 p.m. Contact Person: M. Lourdes Ponce, Agenda: To review and evaluate grant Agenda: To review and evaluate personal Scientific Review Officer, Office of Scientific applications. qualifications and performance, and Review, National Center For Advancing Place: Gaithersburg Marriott competence of individual investigators. Translational Sciences (NCATS), National Washingtonian Center, 9751 Washingtonian Place: National Institutes of Health, 31 Institutes of Health, 6701 Democracy Blvd., Boulevard, Gaithersburg, MD 20878. Center Drive, Building 31, C-Wing, 6th Floor, Democracy 1, Room 1073, Bethesda, MD Contact Person: Adriana Stoica, Ph.D., Conference Room 6, Bethesda, MD 20892. 20892, 301–435–0810, lourdes.ponce@ Scientific Review Officer, Resources and Contact Person: Brian E. Wojcik, Ph.D., nih.gov. Training Review Branch, Division of Senior Review Administrator, Institute (Catalogue of Federal Domestic Assistance Extramural Activities, National Cancer Review Office, Office of the Director, Program Nos. 93.859, Pharmacology, Institute, NIH, 9609 Medical Center Drive, National Cancer Institute, National Institutes Physiology, and Biological Chemistry Room 7W234, Bethesda, MD 20892–9750, Research; 93.350, B—Cooperative 240–276–6368, stoicaa2@mail.nih.gov. of Health, 9609 Medical Center Drive, Room 3W414, Bethesda, MD 20892, 240–276–5664, Agreements; 93.859, Biomedical Research Name of Committee: National Cancer and Research Training, National Institutes of Institute Special Emphasis Panel; NCI wojcikb@mail.nih.gov. Health, HHS) Clinical and Translational R21 & Omnibus (Catalogue of Federal Domestic Assistance R03: SEP–3. Program Nos. 93.392, Cancer Construction; Dated: May 11, 2017. Date: June 26–27, 2017. 93.393, Cancer Cause and Prevention David Clary, Time: 8:00 a.m. to 12:00 p.m. Research; 93.394, Cancer Detection and Program Analyst, Office of Federal Advisory Agenda: To review and evaluate grant Diagnosis Research; 93.395, Cancer Committee Policy. applications. Treatment Research; 93.396, Cancer Biology [FR Doc. 2017–09910 Filed 5–16–17; 8:45 am] Place: Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, Research; 93.397, Cancer Centers Support; BILLING CODE 4140–01–P Bethesda, MD 20852. 93.398, Cancer Research Manpower; 93.399, Contact Person: Saejeong J Kim, Ph.D., Cancer Control, National Institutes of Health, Scientific Review Officer, Special Review HHS) DEPARTMENT OF HEALTH AND Branch, Division of Extramural Activities, Dated: May 11, 2017. HUMAN SERVICES National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W640, Bethesda, MD Melanie J. Pantoja, National Institutes of Health 20892–9750, 240–276–7684, saejeong.kim@ nlaroche on DSK30NT082PROD with NOTICES Program Analyst, Office of Federal Advisory nih.gov. Committee Policy. National Cancer Institute; Notice of Name of Committee: National Cancer [FR Doc. 2017–09912 Filed 5–16–17; 8:45 am] Closed Meetings Institute Special Emphasis Panel; NCI U01 BILLING CODE 4140–01–P Small Cell Lung Cancer Consortium. Pursuant to section 10(d) of the Date: July 11, 2017. Federal Advisory Committee Act, as Time: 12:30 p.m. to 6:00 p.m. amended (5 U.S.C. App.), notice is Agenda: To review and evaluate grant hereby given of the following meetings. applications. VerDate Sep<11>2014 15:18 May 16, 2017 Jkt 241001 PO 00000 Frm 00029 Fmt 4703 Sfmt 4703 E:\FR\FM\17MYN1.SGM 17MYN1


Document Created: 2017-05-17 01:42:12
Document Modified: 2017-05-17 01:42:12
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesJuly 11, 2017.
FR Citation82 FR 22671 
2026 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR